Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

BACKGROUND: There is an ongoing debate about whether clearance of Mycobacterium tuberculosis infection occurs and at what magnitude. Recent studies quantifying "uncertainty zones" of interferon-gamma release assays (IGRAs) provide a more stringent estimate of reversion. RESEARCH QUESTION: When accounting for uncertainty zones through stringent cutoffs, what are the trajectories of IGRAs results over 2 years of testing? STUDY DESIGN AND METHODS: Five cohorts from South Africa, China, Tanzania, and the United States tested with an IGRA three or more times were followed up for stringent conversion and reversion. The annual risk of IGRA reversion was assessed following an IGRA conversion and among those with baseline positivity. RESULTS: A total of 26,596 IGRA measurements were taken over 13,593 years of follow-up (Nparticipants = 7,683). Stringent reversion at year 2 following stringent conversion at year 1 varied between cohorts, occurring in 48% (43/90) for Wantai, 37% (22/59) for QuantiFERON, and 17% (2/12) for T-SPOT.TB, respectively. In the US cohorts, stringent reversion at year 1 following stringent conversion at 6 months was 58% (15 of 26) for QuantiFERON and 18% (12 of 60) for T-SPOT.TB. Stringent reversion at 1 year following baseline positivity occurred in 12% (47 of 404) for Wantai, 21% (10 of 48) for QuantiFERON, and 44% for T-SPOT.TB (45 of 102). In one cohort from China (N = 399; age range, 59 years [interquartile range, 48-67 years]), IGRA reversion was more common in younger participants (adjusted OR [aOR], 0.95; 95% CI, 0.93-0.97) and those without recent close TB exposure (aOR, 0.35 [95% CI, 0.11-1.03] in South Africa; aOR, 0.10 [95% CI, 0.01-0.61] in China). INTERPRETATION: These results suggest high annual rates of IGRA reversion, even with the use of uncertainty zones; reversion rates decreased over time from exposure and at older ages.

Original publication

DOI

10.1016/j.chest.2025.01.031

Type

Journal article

Journal

Chest

Publication Date

03/02/2025

Keywords

Mycobacterium tuberculosis, TB clearance, interferon gamma release assay, transmission